Duration and Efficacy of Azstarys on Adult ADHD Symptoms and Executive Function in Early Evening

Summary

This is a single-site study. One purpose of this trial is to extend the safety and efficacy evidence basis for Azstarys in adults with ADHD. This open-label, treatment study will examine the efficacy of Azstarys on ADHD symptoms using the AISRS 18-item total score on the AISRS-expanded; the Adult ADHD Investigator Symptom Rating Scale. The investigators will also examine Executive Function later in the day (early evening, about 12 hours after first morning dosing).

Timeline

Start

2023-11-13

Primary completion

2024-07-03

Completion

2024-07-17

Drugs

Indications